Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regulatory Mechanism of Intestinal Microorganism in Intervening Mild Cognitive Impairment Based on Multi-modal Neuroimaging Techniques

NCT03991195 is registered in ClinicalTrials.gov with XuanwuH 2 as lead sponsor.

NCT NCT03991195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03991195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regulatory Mechanism of Intestinal Microorganism in Intervening Mild Cognitive Impairment Based on Multi-modal Neuroimaging Techniques
Lead sponsor
XuanwuH 2
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2019
Completion date
March 31, 2022
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, alzheimer type, gut microbiota, mild cognitive impairment, neuroimaging